Cellectis (CLLS) Cash from Financing Activities (2015 - 2026)
Cellectis (CLLS) posted Cash from Financing Activities of -$4.9 million for Q1 2026, down 18.36% on a QoQ basis from -$4.1 million in Q4 2025, and down 19.8% year-over-year from -$6.1 million in Q1 2025.
Cellectis (CLLS) has 12 years of Cash from Financing Activities data on file, last reported at -$4.9 million in Q1 2026.
- In Q1 2026, Cash from Financing Activities fell 19.8% year-over-year to -$4.9 million; the TTM figure through Mar 2026 stood at -$17.6 million (down 124.03% YoY), while the FY2025 annual figure was -$16.8 million, down 118.81% from the prior year.
- Cash from Financing Activities eased to -$4.9 million in Q1 2026, from -$4.1 million in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $78.5 million in Q2 2024 and bottomed at -$13.7 million in Q4 2022.
- A 5-year average of $8.4 million and a median of $1.7 million in 2023 frame the typical range for Cash from Financing Activities.
- Annual changes were most pronounced in 2022 — Cash from Financing Activities tumbled 862.19% — and 2023, when it surged 653.5%.
- Year by year, Cash from Financing Activities stood at -$13.7 million in 2022, then soared by 403.68% to $41.6 million in 2023, then tumbled by 92.97% to $2.9 million in 2024, then sank by 241.54% to -$4.1 million in 2025, then slipped by 18.36% to -$4.9 million in 2026.
- The last three Cash from Financing Activities figures came in at -$4.9 million (Q1 2026), -$4.1 million (Q4 2025), and -$4.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 7.00 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -600,000.00 |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 53,000.00 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -538.80 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -802.20 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 15.71 Mn |
| 10 | Cellectis | 20.83 Bn | 20.62 Bn | - | -4.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.90 Mn |
| Mar 31, 2026 | -4.90 Mn |
| Dec 31, 2025 | -4.14 Mn |
| Dec 31, 2025 | -4.14 Mn |
| Sep 30, 2025 | -4.26 Mn |
| Sep 30, 2025 | -4.26 Mn |
| Jun 30, 2025 | -4.27 Mn |
| Jun 30, 2025 | -4.27 Mn |
| Mar 31, 2025 | -4.09 Mn |
| Mar 31, 2025 | -4.09 Mn |
| Dec 31, 2024 | 2.93 Mn |
| Dec 31, 2024 | 2.93 Mn |
| Sep 30, 2024 | -4.22 Mn |
| Sep 30, 2024 | -4.22 Mn |
| Jun 30, 2024 | 78.51 Mn |
| Jun 30, 2024 | 78.51 Mn |
| Mar 31, 2024 | 11.90 Mn |
| Mar 31, 2024 | 11.90 Mn |
| Dec 31, 2023 | 41.58 Mn |
| Dec 31, 2023 | 41.58 Mn |
| Sep 30, 2023 | 1.69 Mn |
| Sep 30, 2023 | 1.69 Mn |
| Jun 30, 2023 | 19.82 Mn |
| Jun 30, 2023 | 19.82 Mn |
| Mar 31, 2023 | 19.78 Mn |
| Mar 31, 2023 | 19.78 Mn |
| Dec 31, 2022 | -13.69 Mn |
| Dec 31, 2022 | -13.69 Mn |
| Sep 30, 2022 | -4.12 Mn |
| Sep 30, 2022 | -4.12 Mn |
| Jun 30, 2022 | 2.63 Mn |
| Jun 30, 2022 | 2.63 Mn |
| Mar 31, 2022 | 7.68 Mn |
| Mar 31, 2022 | 7.68 Mn |
| Dec 31, 2021 | -1.42 Mn |
| Dec 31, 2021 | -1.42 Mn |
| Sep 30, 2021 | -3.68 Mn |
| Sep 30, 2021 | -3.68 Mn |
| Jun 30, 2021 | 42.84 Mn |
| Jun 30, 2021 | 42.84 Mn |
| Mar 31, 2021 | 9.79 Mn |
| Mar 31, 2021 | 9.79 Mn |
| Dec 31, 2020 | 12.68 Mn |
| Dec 31, 2020 | 12.68 Mn |
| Sep 30, 2020 | 16.54 Mn |
| Sep 30, 2020 | 16.54 Mn |
| Jun 30, 2020 | 1,000.00 |
| Jun 30, 2020 | 1,000.00 |
| Mar 31, 2020 | -1.90 Mn |
| Mar 31, 2020 | -1.90 Mn |
| Dec 31, 2019 | -1.03 Mn |
| Dec 31, 2019 | -1.03 Mn |
| Sep 30, 2019 | -838,000.00 |
| Sep 30, 2019 | -838,000.00 |
| Jun 30, 2019 | -721,000.00 |
| Jun 30, 2019 | -721,000.00 |
| Mar 31, 2019 | -1.28 Mn |
| Mar 31, 2019 | -1.28 Mn |
| Dec 31, 2018 | 164,000.00 |
| Dec 31, 2018 | 164,000.00 |
| Sep 30, 2018 | 1.91 Mn |
| Sep 30, 2018 | 1.91 Mn |
| Jun 30, 2018 | 230.93 Mn |
| Jun 30, 2018 | 230.93 Mn |
| Mar 31, 2018 | 3.49 Mn |
| Mar 31, 2018 | 3.49 Mn |
| Dec 31, 2017 | 953,000.00 |
| Dec 31, 2017 | 953,000.00 |
| Sep 30, 2017 | 39.18 Mn |
| Sep 30, 2017 | 39.18 Mn |
| Jun 30, 2017 | 1.02 Mn |
| Jun 30, 2017 | 1.02 Mn |
| Mar 31, 2017 | 282,000.00 |
| Mar 31, 2017 | 282,000.00 |
| Dec 31, 2016 | 55,000.00 |
| Dec 31, 2016 | 55,000.00 |
| Sep 30, 2016 | 148,452.54 |
| Sep 30, 2016 | 148,452.54 |
| Jun 30, 2016 | -5,649.38 |
| Jun 30, 2016 | -5,649.38 |
| Mar 31, 2016 | 283,474.14 |
| Mar 31, 2016 | 283,474.14 |
| Dec 31, 2015 | 3.44 Mn |
| Dec 31, 2015 | 3.44 Mn |
| Sep 30, 2015 | 350,369.74 |
| Sep 30, 2015 | 350,369.74 |
| Jun 30, 2015 | 215.55 Mn |
| Jun 30, 2015 | 215.55 Mn |
| Mar 31, 2015 | 341,209.41 |
| Mar 31, 2015 | 341,209.41 |